Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Non-Current Debt (2011 - 2023)

Talphera (TLPH) posted Non-Current Debt of $3.3 million for Q1 2023, up 8.52% on a QoQ basis from $3.0 million in Q1 2022, and up 8.52% year-over-year from $3.0 million in Q1 2022.

Analysis

Talphera (TLPH) Non-Current Debt (2011 - 2023) Analysis & Trends

Talphera has reported Non-Current Debt for 13 years, with the latest figure at $3.3 million in Q1 2023.

  • On a quarterly basis, Non-Current Debt rose 8.52% year-over-year to $3.3 million in Q1 2023; TTM through Mar 2023 was $3.3 million, a 8.52% increase from a year earlier, with the FY2021 full-year figure at $5.0 million, down 61.89% from the prior year.
  • Non-Current Debt was $3.3 million for Q1 2023 at Talphera, up from $3.0 million in the prior quarter.
  • The five-year high for Non-Current Debt was $23.8 million in Q2 2019, with the low at $3.0 million in Q1 2022.
  • Average Non-Current Debt over 5 years is $13.1 million, with a median of $13.1 million recorded in 2020.
  • The sharpest annual moves came in 2019 and 2022: Non-Current Debt jumped 507.01% in 2019, then sank 73.0% in 2022.
  • Over 5 years, Non-Current Debt stood at $20.5 million in 2019, then slumped by 35.96% to $13.1 million in 2020, then plunged by 61.89% to $5.0 million in 2021, then slumped by 39.27% to $3.0 million in 2022, then climbed by 8.52% to $3.3 million in 2023.
  • The last three Non-Current Debt figures came in at $3.3 million (Q1 2023), $3.0 million (Q1 2022), and $5.0 million (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 57.30 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 26.25 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.99 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 591.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 7.29 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Talphera 92.90 Mn 92.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3.30 Mn
Mar 31, 2022 3.04 Mn
Dec 31, 2021 5.01 Mn
Sep 30, 2021 6.95 Mn
Jun 30, 2021 9.37 Mn
Mar 31, 2021 11.27 Mn
Dec 31, 2020 13.14 Mn
Sep 30, 2020 14.99 Mn
Jun 30, 2020 17.32 Mn
Mar 31, 2020 19.13 Mn
Dec 31, 2019 20.52 Mn
Sep 30, 2019 21.92 Mn
Jun 30, 2019 23.77 Mn
Dec 31, 2018 3.38 Mn
Sep 30, 2018 5.50 Mn
Jun 30, 2018 7.54 Mn
Mar 31, 2018 9.49 Mn
Dec 31, 2017 11.37 Mn
Sep 30, 2017 13.15 Mn
Jun 30, 2017 14.89 Mn